• Media type: E-Article
  • Title: Abstract 36: Administration of 17β-Estradiol in C57Bl/6N Female Mice Leads to Cardiac Atrophy and Dysfunction via a β-Catenin Mechanism
  • Contributor: Kararigas, Georgios; Zelarayan, Laura C; Toischer, Karl; Hasenfuss, Gerd; Jarry, Hubertus; Regitz-Zagrosek, Vera
  • Published: Ovid Technologies (Wolters Kluwer Health), 2015
  • Published in: Circulation Research, 117 (2015) suppl_1
  • Language: English
  • DOI: 10.1161/res.117.suppl_1.36
  • ISSN: 0009-7330; 1524-4571
  • Keywords: Cardiology and Cardiovascular Medicine ; Physiology
  • Origination:
  • Footnote:
  • Description: <jats:p> The steroid hormone 17β-estradiol (E2) regulates several biological processes. In contrast to its anti-hypertrophic effects under pressure overload, we recently found that E2 induced physiological hypertrophic growth in healthy C57Bl/6J mice but not C57Bl/6N mice. Here, we aimed at the characterization of the effects of E2 in C57Bl/6N mice and tested the hypothesis that β-catenin mediates these E2 effects. Following ovariectomy, 2-month-old C57Bl/6N wild-type and cardiac-specific β-catenin-deleted (β-cat <jats:sup>Δex2-6</jats:sup> ) mice were randomized to an E2-containing or soy-free (control, CON) diet ( <jats:italic>n</jats:italic> = 7-13/group). Cardiac function was examined by echocardiography following established procedures. The 3-month physiological dose of E2 led to a higher relative uterus weight compared with CON ( <jats:italic>P</jats:italic> &lt; 0.001) in both WT and β-cat <jats:sup>Δex2-6</jats:sup> mice. The relative heart weight was significantly reduced by E2 compared with CON in WT mice ( <jats:italic>P</jats:italic> &lt; 0.001), while there was no significant effect in β-cat <jats:sup>Δex2-6</jats:sup> mice. Cardiomyocyte cross-sectional area was also significantly decreased by E2 ( <jats:italic>n</jats:italic> = 5-7/group; <jats:italic>P</jats:italic> &lt; 0.001) compared with CON in WT mice, while there was no significant effect in β-cat <jats:sup>Δex2-6</jats:sup> mice. Echocardiography revealed a significant decrease in septum width ( <jats:italic>P</jats:italic> &lt; 0.001) and posterior wall thickness ( <jats:italic>P</jats:italic> &lt; 0.01) in E2 treated WT mice compared with CON, while there was no significant effect in β-cat <jats:sup>Δex2-6</jats:sup> mice ( <jats:italic>n</jats:italic> = 8/group). These E2-induced structural changes in WT mice were accompanied by a significant decrease in cardiac function, namely a 23% decrease in fractional shortening compared with CON ( <jats:italic>P</jats:italic> &lt; 0.05), while there was no significant effect in β-cat <jats:sup>Δex2-6</jats:sup> mice. Immunoblotting revealed a significant increase in the levels of the ubiquitin ligase and key regulator of proteasome-dependent protein degradation muscle-specific RING finger protein 1 (MuRF1) by E2 compared with CON in WT mice ( <jats:italic>P</jats:italic> &lt; 0.05), while there was no significant effect in β-cat <jats:sup>Δex2-6</jats:sup> mice. Although we hypothesized increased autophagic activity, we found no effect on the autophagy-related protein LC3 in WT or β-cat <jats:sup>Δex2-6</jats:sup> mice. In conclusion, our surprising findings show that E2 leads to cardiac atrophy and dysfunction in C57Bl/6N mice via a β-catenin mechanism seemingly in an autophagy-independent manner. </jats:p>
  • Access State: Open Access